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Abstract
Human mesenchymal stem cells (hMSCs) hold great potential for clinical applications in
regenerative medicine. However, hMSCs occur at a very low frequency in bone marrow so the
clinical use as cellular therapeutics requires suitable techniques for isolation and expansion.
Furthermore, these cells can be expanded in vitro for only limited passage numbers before they
reach a senescent state. Previous studies have shown that long term culture of hMSCs results in
the decrease in proliferation rates, changes in genomic expressions, increase in cell sizes, and
other morphological changes. Currently the mechanisms of hMSC aging and biomarkers
associated with it have not been well either understood or established. The change of hMSC
phenotype during serial sub-culture must be taken into account prior clinical applications. In this
study, the protein expression profiles of serially sub-cultured hMSCs from passage 3 to passage
9 over 6 weeks were investigated using proteomics approaches. Human MSC proteins were
separated using two-dimensional electrophoresis and differentially expressed proteins were
identified with PDQuest 8.0 and MALDI-TOF Mass Spectroscopy. The significant differences of
protein expression levels were investigated using ANOVA test. It was observed that the cell size
also increases in late passages compared to early passages. There was more number of protein
dots expressed on pH 4 to 7 gels compared to pH 6-11 gels. Differentially expressed hMSC
proteins were normalized and clustered together and histograms were obtained to determine the
proteins that follow similar trend in their expression. In addition, image analysis was performed
to determine the overall intensity of proteins in each passage. Twenty-one differentially
expressed hMSC proteins were successfully identified via Mass Spectroscopy and database
searching. It was observed that Calreticulin, Glyceraldehyde-3-phosphate dehydrogenase, and
alpha-crystallin B chain were up regulated in protein expression while Moesin (C-terminal frag),

Poly (rc)-binding protein, Alpha-tropomyosin, Annexin A2, and Galectin 3 were down regulated.
Similarly, it was found that Vimentin, Beta actin, Nucleophosmin, and Heat shock protein 70 (Nterminal frag) showed up regulation in protein expression at initial passages and down regulation
at

late

passages

while

Transgelin,

Prolyl

4-hydroxylase

subunit

alpha-2,

Phosphatidylethanolamine-binding protein 1, Fructose-bisphosphate aldolase, and Alpha-enolase
showed down regulation in early passages and up regulation in late passages. Such identification
allows for the characterization and clarification of biological mechanisms, targets of drugs, and
biomarkers that play vital role during cellular aging of hMSCs.
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I. Introduction
1. Stem Cells
Stem cells have remarkable potential to generate new stem cells (self-renewal) and to
differentiate into other specialized cells of a tissue1, 2. In other word, during stem cell division
each new daughter cell has ability to either remain a stem cell or undergo cellular differentiation
to become another type of cell with more specialized functions. There are mainly two types of
stem cells: embryonic stem cells and adult stem cells. Embryonic stem cells are isolated from
inner cell mass of early stage embryos that possess significant proliferative capacity and
potential to differentiate into all tissues2, 3.
Adult stem cells are undifferentiated cells found among differentiated cells in tissue or organ
that can be isolated from various tissues including bone marrow, skin, muscle, brain, liver,
breast, and pancreas2. Adult stem cells are found in these tissues at a very low frequency where
they may remain quiescent (non-dividing) for many years until they are activated by disease or
tissue injury. Given the appropriate conditions, adult stem cells have ability to differentiate into a
number of different cell types. The main function of these cells in a living organism is to
maintain and repair the damaged tissues and organs2, 4. Adult stem cells have many significant
clinical applications such as bone marrow derived stromal cells have been used in transplants4.
Currently, research on adult stem cells has become an evolving field because these cells may
become the basis of therapies for many serious diseases if the differentiation of adult stem cells
can be controlled in the laboratory.
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Stem cells hold great potentials for clinical applications in regenerative medicine by
enhancing tissue repair, treating degenerative diseases and also improving dysfunction associated
with normal aging2. Understanding the capacity of stem cell to retain these potentials throughout
the lifespan or it undergoes aging process resulting its decreased stem-stage, has become
significant area of investigation. However, the progress in this field is still in very early stage due
to lack of suitable techniques, appropriate markers, and assays to identify stem cells1, 2, 3. In this
study, cellular aging of stem cells was the focus, and protein expression profiles of serially
subcultured human mesenchymal stem cells (hMSCs) were investigated using proteomics
approaches.

2. Origin and Significance of Human Mesenchymal Stem Cell
Initially, Friedenstein et al. described mesenchymal stem cell (MSC) as spindle-shaped
colony forming unit fibroblasts (CFU-F) which can be isolated from bone marrow as plastic
adherent fibroblastic cells5. Later, it was investigated that CFU-F derived stromal cells are the
distinct population in bone marrow which has potential to differentiate towards lineages of
mesenchymal origin6. Recently, several studies have reported that these bone marrow derived
stromal cells can also differentiate into cells from unrelated germline lineages by undergoing
transdifferentiation6. Caplan et al. considered bone marrow derived stromal cells as stem cells for
the first time and named mesenchymal stem cell due to their capacity for self-renewal and
differentiation6, 7. In bone marrow, stromal cells are initially very rare and heterogeneous
population of cells that contain mixture of stem/progenitor cells at different stages of
commitment to mesodermal lineage and only a low frequency of multi-potential self-renewing
stem cells (figure 1) 6. Different cell surface markers have been proposed to isolate hMSCs and
2

they can be identified by their expressions towards various clusters of differentiation (CD)
antigens such as STRO-1, CD105, CD73, CD44, CD71, CD271, and CD906, 8. In contrast,
hMSCs do not express hematopoietic lineage markers CD14, CD31, CD34, and CD45 or the costimulatory molecules CD80, CD86, and CD406, 8. In a recent study, Bianco et al. demonstrated
CD146 as a positive selectable marker for hMSCs in a fresh tissue3.
Human mesenchymal stem cells are the multipotent adult stem cells that have potential to
proliferate and differentiate into various cell types including adipocytes, chondrocytes, and
osteocytes5, 6, 7. Structurally, hMSCs are long thin cell bodies with large nucleus with high self
renewing and multipotency capacity (figure 1). Thus, hMSCs have great importance in many
clinical applications as they have potential for tissue repair. As a result, hMSCs are tested in a
large number of clinical trials and possess high hope in regenerative medicine.

Figure (1): Self-renewal and differentiation capacity of Mesenchymal Stem Cell towards the
mesodermal lineage. The dashed arrows show their reported ability to transdifferentiate into
cells of other lineages (ectoderm and endoderm) 6.
3

Since hMSCs are found at a very low frequency in bone marrow, these cells need to be
cultured and expanded under in vitro conditions prior to therapeutic applications. Hence, the
clinical use of hMSCs currently depends on in vitro culture isolation and expansion. However,
the techniques for isolation and amplification of hMSCs in culture are highly variable and it is
difficult to maintain and propagate these cells in culture for long term still maintaining their
capacity to self-renew and differentiate. Moreover aging, phenotype and expansion potential of
hMSCs still needs to be further studied due to variable nature of hMSC isolation and culture
expansion.

3. Human Mesenchymal Stem Cell Aging
Aging is a physiological process that results in decrease in overall tissue function and a
delayed response to tissue damage. It would be necessary to identify the factors that influence
stem cell activity in order to understand the processes that contribute to declining stem cell
functions with age9, 10. From the perspective of tissue regeneration and repair, it is important to
understand the mechanisms of hMSC aging because there are evidences that beneficial functions
of hMSCs may become handicapped with age. Previous studies have reported that there is agerelated decline in the number of MSC in the bone marrows of rodents, monkeys, and humans10.
To date, hMSCs are tested in a large number of clinical trials taking into account their paracrine
effect, immunomodulatory activity, and differential potential11. However, their long term culture
might have therapeutic consequences that have been hardly addressed on these ongoing trails. It
is still not clear how many passages, population doublings or senescence-associated molecular
changes are acceptable to provide optimal therapeutic effect for the different applications11, 12.
Therefore, the clinical use of hMSCs as cellular therapeutics requires standardized techniques for
4

isolation and expansion and therapeutic effect on long term culture of hMSCs need to be taken
into account for clinical applications.
Currently, hMSCs can be only cultured and expanded for a limited time in vitro before they
reach a senescent state. Previous studies have shown that long term culture of hMSCs in 2D
culture results decrease in proliferation rate, increase in cell size, changes in gene expression,
and differential potential is affected11. Bruder et al. demonstrated culture expanded hMSCs have
spindle-shaped fibroblastic morphology and they stop proliferating before or at 40 population
doublings at which time the cells become bigger and more flattened3,

13

. In addition, hMSCs

from older donors have a slower proliferation rate than younger donors from initial cell passage
until the culture senesces3. The morphology of hMSCs from old donors is larger and flattened
compared with morphology of hMSCs from young donors from the initial passage3.
Furthermore, hMSC frequency in bone marrow samples from old donors is significantly lower
than that of young donors14. Studies have shown that hMSC aging is associated with telomere
shortening, DNA damage, and protein damage.
i. Telomere Shortening
In 1961, Hayflick et al. described an increase in cell size in vitro is associated with
senescence15. During in vitro proliferation of Human fibroblasts and in vivo aging, one of the
mechanisms responsible for cell senescence is loss of telomere length. Telomeres, the potential
cell-intrinsic trigger to induce replicative senescence, are the structure that protects chromosomes
ends and are largely maintained by enzyme telomerase16, 17. In 2002, Samper et al. documented
telomerase-deficient hematopoietic stem cells reduced long term repopulating capacity that is
associated with an increase in genetic instability18. Studies have been done to measure the
5

telomere length of hMSCs with varied results. Baxter et al. described the telomere length in
hMSCs from young donors is significantly longer compared to old donors and the average loss in
vivo could be estimated at 17 bp/year. They demonstrated that there was progressive loss of
telomere length with each cell division upon in vitro culture and hMSCs stop undergoing cell
division when telomere length reaches about 10 kb14. Guillot et al. showed that telomere length
of hMSCs derived from postnatal and prenatal donors are 7 – 8 kb and 11 – 13 kb respectively19.
Similarly, Bonab et al. investigated average telomere length of hMSCs derived from postnatal
donor is 7 – 9 kb20 and Meareschi et al. demonstrated hMSCs telomere length from young donor
to be 10 kb21. These studies have shown that telomere shortening occurs up to 1.5 – 2 kb upon
passage during in vitro culture3, 14, 19, 20, 21.
ii. DNA Damage
There are numerous copy errors in each replication round of the genome during cell divisions
which are corrected by proofreading and editing mechanisms38. When DNA is damaged, the
appropriate cellular response is an initial attempt at repair. However, if the damage is too
extensive then a signaling cascade triggers cellular senescence or death. The cumulative extent
of DNA damage during life time of a stem cell may potentially result apoptosis16. Studies show
that more abundant transcripts are involved in cell cycle promotion, chromatin regulation, and
DNA repair in fetal than postnatal hMSCs23. Shibata et al. found that expression of the p16INK4A
gene is associated closely with senescence of hMSCs and is potentially silenced by DNA
methylation during their long term culture22. It was shown that stem cell aging is modified by
cyclin dependent kinase inhibitor p16INK4a. Inhibition of p16INK4a may improve the physiological
impact of aging on stem cells37. Similarly, Wagner et al. demonstrated that gene involved in cell
6

cycle, DNA replication, mitosis and DNA repair are significantly down-regulated in late
passages of Human MSCs16.
iii. Protein Damage
An age-related increase in oxidative protein damage could have significant physiological
consequences to an organism as proteins are responsible for diverse cellular functions such as
signal transduction, mitosis, transport systems, and chaperone activity16. Oxidative carbonylation
has significant effect on protein function and removal39,

40, 41

. Many studies have documented

that protein carbonylation increases and form high-molecular weight aggregates that accumulate
with age16. Clinical studies show that such carbonylated aggregates can become cytotoxic and
have been associated with large number of age-related disorders including Alzheimer’s disease,
Parkinson’s disease, and cancer16,

39, 40

. It would be interesting to study the role of protein

damage during stem cell aging, self-renewal, and differentiation.
Currently, there are only few studies have been done to monitor the side effects of hMSCs
cellular aging on clinical applications. Thus, to study factors responsible for the cellular aging of
hMSCs, establish a method to maintain their stem-stage during long term culture, and maximize
the effectiveness of hMSCs in clinical applications have become important area of investigation.

4. Investigation of hMSC Aging using Proteomic Approaches
A large number of studies have been done using genome-wide analysis of mRNA to study
important factors responsible for MSC self renewal and differentiation. It is a powerful approach
to measure mRNA expression. However, studies have shown that modifications at mRNA level
do not always correlate with protein expression profile42. Tian et al. investigated different
7

correlation of mRNA and protein levels in hematopoietic stem cells using DNA micro arrays and
quantitative proteomic techniques24. Thus, more reliable technique is needed to study and
investigate hMSCs aging factors, self renewal, and differentiation.
Proteomics, first coined in 1995, can be defined as the analysis of the entire protein
complement in a given cell, tissue, or organism25. Proteomics of hMSCs can help to identify all
the proteins of a cell rather than each one individually and also to create a complete three
dimensional map of the cell indicating where the proteins are located26. It is a significant
technique that has ability to identify differentially expressed hMSCs proteins. Such identification
can allow characterizing biological roles, clarification of biological mechanisms, and
identification of therapeutic targets, and biomarkers. In addition, proteomics helps to detect
proteins with post-translational modifications such as proteolytic maturation, glycoylation or
phosphorylation25. Also, self-renewal and differentiation of hMSCs have correlation with
signaling pathways and phosphorylation of transcription factors25. Hence, proteomics technique
can be a significant tool to study and investigate factors responsible for hMSCs aging.
i. Proteomics Methods
A typical proteomic experiment to study the protein expression profile can be categorized into
followings: separation and isolation of proteins using electrophoresis or chromatography
technique, acquisition of protein structural information for the purpose of identification and
characterization using antibodies or mass spectroscopy, and database mining25, 26. In this study,
protein expression profile using two-dimensional (2D) electrophoresis technique followed by
PDQuest image analysis and mass spectroscopy for protein identification, were studied to
understand the potential factors that may be responsible for cellular aging of hMSCs.
8

A. Two-Dimensional Gel Electrophoresis (2-DE)
In 1975, O’Farrell developed a technique for the separation of proteins by two dimensional
polyacrylamide gel electrophoresis (2-DE)

27

. He applied isoelectric focusing (IEF) to protein

samples prior to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) to
pioneer the concept of two dimensional gel electrophoresis which has become a attractive
method for the analysis and detection of complex proteins mixture27. One of the greatest
challenges in proteomics is the reproducibility of these complex protein mixtures while retaining
the qualitative and quantitative relationships. Introduction of immobilized pH gradients have
improved the reproducibility of 2-DE and the use of coommassie blue, silver staining, and
fluorescence dyes have maximized the sensitivity of protein detection28, 29.
Currently, 2-DE has become a prevailing tool as a single gel can resolve thousands of
proteins. A large number of studies have been done using two-dimensional gel electrophoresis to
study complex protein mixture from a crude cell lysate of biological species. Celebi et al. studied
proteome analysis of rat bone marrow MSCs differentiation using 2-DE where they investigated
23 new proteins either up or down regulated during differentiation experiment30. Nasrabadi et al.
demonstrated significant changes on 127 proteins during monkey embryonic stem cell
differentiation using 2-DE technique. From mass spectroscopy, they identified 95 differentially
expressed proteins that are involved in cell cycle progression and proliferation, cell growth,
transcription and chromatin modeling, translation, metabolism, energy production, and Ras
signaling31. In 2006, Sun et al. also used 2-DE method to study proteomic analysis during serial
subculture and Osteogenic differentiation of hMSCs. They investigated T-complex protein 1 α
subunit (TCP-1α) that is associated with cell proliferation, cell cycle, morphological changes,
9

and apoptosis gradually decreased during serial sub culture. In addition, they found that chloride
intracellular channel 1 (CLIC1) and acidic ribosomal phosphoprotein P0 were down regulated,
while annexin V, LIM, SH3 domain protein 1 (LASP-1), and 14-3-3 protein gamma (YWHAG)
were significantly up regulated during Osteogenic differentiation32.
2-DE has also ability to resolve hMSCs proteins that have undergone post-translational
modifications due to protein phosphorylation, mRNA splicing, and proteolytic processing26. It is
possible using 2-DE because many types of proteins modifications confer a difference in a
charge and change in mass on the protein. This technique can become significant analytical tool
to investigate protein expression profile of hMSCs qualitatively and quantitatively26. In a gel, the
appearance and disappearance of hMSCs protein spots can reveal differential protein expression
and intensity of those spots can provide quantitative information about protein expression level.
In addition, 2-DE can be also used to resolve, characterize, and map hMSCs proteins. Hence, two
–dimensional gel electrophoresis can reveal significant information regarding Human MSCs selfrenewal, differentiation, and protein markers that may be responsible for the cellular aging.
Two-dimensional gel electrophoresis separates proteins in two independent steps. The first
dimension is isoelectric focusing (IEF) in which proteins are separated according to their
isoelectric points (PI) and the second dimension is sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) in which proteins are separated based on their molecular weights.
Each spots on the gel corresponds to a single protein in the sample.

10

Figure (2): Overview of two-Dimensional Gel Electrophoresis. This method separates proteins
based on charge (first dimension) followed by molecular weights (second dimension).

i. Isoelectric Focusing
During isoelectric focuing, the proteins are separated according to their isoelectric point (PI)
where the overall protein charge equals to zero. The isoelectric focusing effect of IEF allows
proteins to be separated on small charge differences. The resolution of the separation is
determined by slope of pH gradient and electric field25,

26, 29

. The total charge of a protein

molecule corresponds to the sum of all the positive and negative charges of its amino acids side
chains and amino- and carboxyl- termini26. Proteins are amphoteric and they can carry positive,
negative, or no charge depending upon the pH of the surroundings. Proteins are positively
charged at pH values below their PI and negatively charged at pH values above their PI. When
an electric field is applied during isoelectric focusing, proteins move to the position in a pH
gradient where its net charge is zero26. Theoretically, proteins with net positive charge will
11

migrate towards cathode and become less positive as they move through pH gradient until they
reach their PI. While the proteins with net negative charge will migrate towards anode and
become less negative as they move through pH gradient until they reach their PI26, 28, 29.
ii. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
The second dimension of 2D electrophoresis involves separation of proteins according to their
molecular weights in a polyacrylamide gel containing sodium dodecyl sulfate (SDS). SDS is an
anionic detergent that forms necklace-like structure complexes with proteins in a ratio of 1.4
grams SDS per gram protein26. SDS masks the charge of the proteins making the necklace-like
structure complexes with a constant negative charge per unit mass. Reducing agent such as
Dithiothreitol (DTT) used during SDS-PAGE helps to break the disulfide bonds present in the
proteins26,

29

. Thus, the electrophoretic separation of proteins within a polyacrylamide gel

depends mainly on their molecular weights when these proteins are treated with SDS and
reducing agents.
B. Mass Spectroscopy
Mass Spectroscopy is an instrument that uses an analytical technique to ionize a sample and
measure the mass-to-charge ratio of resulting ions. It is a significant method in biological
research for the characterization of proteins and has capacity to analyze samples from gas, liquid,
or solid state. It provides qualitative and quantitative information on the elemental, isotopic, and
molecular composition of organic and inorganic samples33,
ionization

of

proteins

are

electrospray

ionization

34, 35

(ESI)

. Two primary methods for
and

matrix-assisted

laser

desorption/ionization (MALDI).
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Mass spectroscopy has become significant tool in proteomic research to investigate the
identity, amount, modifications of the proteins. Mass spectroscopy determines protein structural
information including peptide masses and amino acid sequences that helps in protein
identification. Another application of mass spectroscopy is the protein quantification that helps
to measure the level of protein expression in the samples35, 36. In addition, it can be also used to
determine the type and location of proteins with post-translational modifications such as protein
phosphorylation36. It is important to study such modifications because it may be associated with
activity and function of proteins.
Therefore, the study of hMSC proteins using two dimensional gel electrophoresis and mass
spectroscopy can reveal factors that may be responsible to the phenotype change of these cells
during self-renewal, differentiation, and aging. The post translational modifications of hMSC
proteins can provide significant information regarding the activity and function of differentially
expressed proteins responsible for cellular aging. Thus, such identification allows for the
characterization and clarification of biological mechanisms, targets of drugs, and biomarkers that
play vital role during cellular aging of hMSCs.

5. Overall Hypothesis and Objective
We hypothesized that hMSCs undergo continuous changes of the protein expression during
conventional long term 2D culture in vitro. The overall objective of this study is to discover
hMSC aging biomarkers in the traditional 2D long term culture by proteomics approaches. The
change in protein expression profile of hMSCs during serial sub-culture in conventional 2D
culture was investigated using proteomics approaches. Identification of such differentially
expressed proteins would provide new information about – biological mechanisms during post
13

translational modifications of hMSC proteins, proteins that may be responsible for self-renewal,
differentiation and cellular aging, a method to culture hMSCs for long term, and maximize the
use of hMSCs in regenerative medicine.

14

II. Materials and Methods
1. Human Mesenchymal Stem Cell Isolation and Culture
Human bone marrow was purchased from AllCells, LLC, Emeryvill, CA from a 28 years old
donor. Human mesenchymal stem cells were isolated following RosetteSep method and
expanded in culture using CFU-F assay. Fluorescence-activated cell sorting (FACS) analysis of
hMSCs was performed that showed positive for surface markers CD146, CD44, CD29, and
CD147 and negative for hematopoietic cell markers CD45 and CD34. For 2D culture, the cells
were plated in phenol red free Dulbecco’s modified Eagle’s medium – low glucose (DMEM;
Sigma Aldrich), supplemented with 10% Fetal Bovine Serum (FBS; Atlanta Biologicals) and 1%
Penicillin Streptomycin (P/S; Gibco, Invitrogen) and cultured at 37oC and 5% CO2. The cells
were seeded 0.375 x 106 cells in one T75 tissue culture flask and passaged once per week to
obtain passage 3 to passage 9 samples. These adherent cells were cultured for 7 days with media
changes every 3 days and phase contrast images were taken using bright field inverted
microscope (Axiovert 40 CFL). After 7 days, the cells were harvested by incubation with 3 ml of
0.25% trypsin/1 mM EDTA (Gibco, Invitrogen) at 37oC and 5% CO2, and centrifuged at 150
rpm (Beckman Coulter, Allegra X-15R Centrifuge) for 5 minutes. The harvested cells were
defined as passage 3 and replated cells were cultured and serially sub-cultured until passage 9
with constant cell density (0.375 x 106 cells per T75 flask) for all passages.

2. Sample Preparation for Proteome Analysis
Cell pellets were washed once with cold Phosphate Buffered Saline (PBS). Then the pellets
from two T75 culture flasks were homogenized and suspended in 500 µl lysis buffer containing
15

9.5 M Urea (Sigma Aldrich), 2% w/v CHAPS (GE Healthcare), 1% w/v Dithiothreitol (GE
Healthcare), 0.8% Pharmalyte pH 3.0 – 10.0 (GE Healthcare), and 5 tablets of protease inhibitor
(Roche Diagnostics Ltd., Lewes, UK). The suspension was incubated on ice for 30 minutes by
votexing once every 10 minutes, centrifuged at 16,100 x g for 12 minutes at 4oC, and
supernatants were collected. The cell lysate were washed with Ready Prep 2D clean up kit
following Bio-Rad protocol to remove substances that may interfere 2D/IEF samples. The
protein content of the supernatant was determined by the Bradford assay and samples were
stored at -80oC until use.

3. Two-Dimensional Gel Electrophoresis
Two-dimensional electrophoresis was carried out according to manufacturer’s instructions
(Bio-Rad). For the first dimension, 200 µl of rehydration buffer containing 8 M urea (Sigma
Aldrich), 0.5% w/v CHAPS (GE Healthcare), 0.2% w/v DTT (GE Healthcare), and 0.2% w/v
Pharmalyte (GE Healthcare) with 200 µg of hMSCs protein was applied to 11 cm long IEF
strips, pH 4 – 7 (Bio-Rad) for overnight passive rehydration and subjected to isoelectric focusing
using a Protean IEF Cell at 20oC. For 11cm IEF strip pH 6 – 11 (Bio-Rad), 0.2 % w/v DTT of
rehydration buffer was replaced with Destreak reagent. Isoelectric focusing was performed
following Bio-Rad protocol: 8000 V at 20oC for 30000 V.hours. The focused strips were
equilibrated twice for 10 minutes in equilibrium buffer. The first equilibrium was performed in a
solution containing 6 M urea (Sigma Aldrich), 30% w/v glycerol (Sigma Aldrich), 2% w/v SDS
(Fischer Scientific), 2% w/v DTT (GE Healthcare), Bromophenol blue, and 50 mM Tris-HCl pH
8.8 (Sigma Aldrich). The second equilibrium was performed by replacing 2% w/v DTT by 5%
w/v Iodoacetamide (Sigma Aldrich) in first equilibrium solution. The second dimension was
16

carried out on a running buffer containing 25 mM Tris (Sigma Aldrich), 192 mM Glycine
(Sigma Aldrich), and 0.1% SDS (Sigma Aldrich) using Protean Dodeca Cell system (20 cm x 25
cm, Bio-Rad) by loading the equilibrated IEF strips on the top of 12.5 % polyacrylamide gel
(13.3 cm x 8.7 cm). Molecular masses were determined by running the protein standards
containing Myosin (193 kDa), β-Galactosidas (122 kDa), BSA (80 kDa), Carbonic anhydrase (38
kDa), Soybean trpsin inhibitor (31 kDa), Lysozyme (16 kDa), and Aprotinin (6 kDa), covering
the range of 6 kDa to 193 kDa. The gels were run at 20oC at 200 V until the bromophenol dye
marker reached at the bottom of the gel.
The gels were stained with Coomassie Blue (Bio-Rad and Invitrogen) for 1 hour after
washing with three changes of deionized water for 10 minutes per wash. The gels (pH 6 to 11)
stained with Coomassie blue (Bio-Rad Laboratories, Hercules, CA) were destained for 2 hours
using 40% methanol and 10% acetic acid while the gels (pH 4 to 7) stained with Coomassie blue
(Invitrogen, Carlsbad, CA) were destained for 2 hours using deionized water. Images were
obtained after 4 hours using two successive destaining washes with ChemiDocTM XRS
Molecular Imager (Bio-Rad Laboratories, Hercules, CA).

4. Image Analysis
Image pro analysis was performed to calculate the overall expression of hMSCs protein spots
on pH 4 to 7 and pH 6 to 11 gels. Image analysis were performed using PDQuest software
version 8.0 (Bio-Rad Laboratories, Hercules, CA) according to the manufacturer’s instruction.
The images were aligned ensuring corresponding proteins were matched. Gels for each passage
were comparatively analyzed using PDQuest software assigning passage 3 as a control. The
protein spots were modeled mathematically as three-dimensional Gaussian distribution and
17

maximum absorption after correction of the raw image and background subtraction were
determined. Spot intensities were normalized to total quantity in valid spots in each gel image,
and quantitative and qualitative image analysis was performed. Manual matching was performed
by visual inspection in order to verify the automatic spot detection and obtain image pattern as
similar as possible to the three biological triplicates and master gel (control). ANOVA analysis
was performed with a confidence interval of 95% in order to determine the significance
difference of a protein spots among different passages.

5. In Gel Digestion and Mass Spectroscopy
All procedures were performed at Protein Core Facility at Columbia University Medical
Center. The protein spots were transferred to a clean tube containing DTT and Tris, pH 8.5
followed by incubating in a heating block at 55oC for 1 to 2 hours. Next, the tube was allowed to
cool at room temperature, liquid was removed, and iodoacetamide and Tris, pH 8.5 were added
to the tube. The tube was incubated in the dark for 30 minutes and the liquid were removed. The
gels were washed twice with Tris, pH 8.5 and 30% acetonitrile for 20 minutes in an orbital
shaker followed by 100% acetonitrile for 1 – 2 minutes. The solution was discarded and the gel
spots were dried using a Speed-Vac concentrator for 30 minutes. The gel spots were digested by
adding modified trypsin (Sequencing grade, Roche Molecular Biochemicals) and Tris, pH 8.5.
The tubes were incubated overnight in a heating block at 32oC and peptides were extracted with
2X of 50% acetonitrile and 2% Trifluoroacetic acid (TFA). The extracts were dried and
resuspended in a matrix solution.
The matrix solution was prepared by adding 4-hydroxy-α-cyanocinnamic acid in 50%
acetonitrile and 0.1% TFA. Two internal standards, angiotensin and ACTH 7-38 peptide, were
18

added to the matrix solution. The digest was dissolved in matrix/standard solution and spotted
onto the sample plate. The spot was dried and washed twice with water and MALDI mass
spectrometric analysis was performed in the linear mode using Applied Biosystems Voyager DE
Pro mass spectrometer. The peptide masses obtained from mass spectroscopy were entered into
search ExPASy proteomics server and MASCOT programs to find the NCBI and GenPept
databases for a protein match. Error tolerance was set at 0.5 Da for average masses.
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III. Results
1. Human MSCs Morphology during Serial 2D Subculture
Phase contrast images in figure 3 shows that hMSCs acquire significant changes in the
morphology during serial subculture in vitro for long term in 2D culture. Spindle-shaped hMSCs
increases their sizes and become more flattened in their late passage (figure 3M) compared to the
early passage (figure 3A). It was also noticed that the proliferation rate has been decreased on the
late passages during serial subculture of hMSCs.
10X Objective

20X Objective

Passage 3

Passage 4

20

10X Objective

20X Objective

Passage 5

Passage 6

Passage 7

Passage 8

21

10X Objective

20X Objective

Passage 9

Figure (3): Phase contrast images captured on day 7 show morphological changes during serial
subculture of hMSCs in 2D culture.

2. Two Dimensional Electrophoresis and Image Analysis
Figures 4A and 4B show the hMSC proteins from passage 3 and passage 9 respectively
separated on a SDS-PAGE gel after 2D electrophoresis. There were visually noticeable
differences in the protein expression in late passage compared to early passage. It was observed
that the intensity and boundary area of the proteins expression during early passages were higher
than late passages (figures 4A and 4B). In addition, the number of proteins expressed on a gel
from passage 3 is higher than that of passage 9 on pH 4 to 7 gels and protein expression from
passage 3 were slightly higher than passage 9 on pH 6 to 11 gels (Table 1).
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Figure (4A): 2D gel electrophoresis of passage 3 hMSCs (200 µg) expanded in vitro on 2D
culture condition for 7 days.

Figure (4B): 2D gel electrophoresis of passage 9 hMSCs (200 µg) expanded in vitro on 2D
culture condition for 7 days.
Image pro plus analysis calculated total intensity expression of the protein spots on pH 4 to 7
gels and pH 6 to 11 gels over passage 3 to passage 9 (figure 5). The analysis showed that total
intensity of the protein expression slightly decreases from passage 3 to passage 7 on pH 4 to 7
gels. In addition, there was a sudden down regulation in the overall expression in passage 8 and
passage 9 compared to earlier passages.

Similarly, it was observed that the total protein

expressions on pH 6 to 11 gels does not change much when hMSCs were cultured and expanded
in 2D culture condition from passage 3 to passage 9 (figure 5).
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Figure (5): Image pro plus analysis of overall expression of protein spots on pH 4 to 7 and pH 6
to 11 gels.
There were more proteins detected on the pH 4 to 7 gels compared to pH 6 to 11 (figures 4A,
4B, 6). The manual matching of protein spots using PDQuest image analysis tool shows
significant difference in number of protein spots matched among the triplicates gels over
different passages (table 1 and figure 6). It was observed that the number of matched proteins
decreased from passage 3 to passage 6 and the number started to increase from passage 6 to
passage 9 on pH 4 to 7 gels while the matching numbers were slightly higher from passage 3 to
passage 7 and it started to decrease in passage 8 and passage 9 on pH 6 to 11 gels (figure 6).
Passage Number

Matched to all gels within same Matched to all gels within same
passage (pH 4 to 7)

passage (pH 6 to 11)

Passage 3

330

180

Passage 4

278

178

Passage 5

244

186

Passage 6

176

205

24

Passage 7

210

203

Passage 8

301

158

Passage 9

227

164

Table (1): Manual matching of hMSCs proteins assigning passage 3 as master and control gel.
Results from the manual matching of protein spots from pH 4 to 7 and pH 6 to 11 gels are
also illustrated in figure 6 which suggests the number of proteins expressed during serial
subculture in 2D environment have variations. In addition, figure 6 provides information about
the appearance and disappearance of hMSCs protein spots that can be investigated during serial
sub culture in 2D culture condition.

Figure (6): Histogram to show the manual match of hMSCs protein spots over different passage
numbers.
Further quantitation of protein spots reveals different proteins that follow similar trends in the
expression along with passage. Figures 7 and 8 show clustering of hMSC proteins, normalized
with respect to highest intensity of the protein dot among gels and separated using pH 4 to 7 IEF
strip for the first dimension, that follow similar trend in the expression. From the graphs, it was
observed that there were differences in protein expression level of hMSC proteins along with the
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different passage. The remaining graphs for clustering of the hMSCs proteins expression are
shown in Appendix 3.

Figure (7): Clustering of hMSCs protein expression along with different passage numbers.
Proteins were separated using 2D electrophoresis with pH 4 to 7 for first dimension and 12.5%
Tris HCl gel for second dimension.

Figure (8): Clustering of hMSCs protein expression along with different passage numbers.
Proteins were separated using 2D electrophoresis with pH 4 to 7 for first dimension and 12.5%
Tris HCl gel for second dimension.
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Figure (9): Clustering of hMSCs protein expression along with different passage numbers.
Proteins were separated using 2D electrophoresis with pH 6 to 11 for first dimension and 12.5%
Tris HCl gel for second dimension.

Figure (10): Clustering of hMSCs protein expression along with different passage numbers.
Proteins were separated using 2D electrophoresis with pH 6 to 11 for first dimension and 12.5%
Tris HCl gel for second dimension.
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Figures 9, 10 and Appendix 4 show clustering of hMSC proteins, normalized to highest intensity
of protein dots among gels and separated using pH 6 to 11 IEF strip for the first dimension, that
follow similar trend in their expression.
Analysis of Variance (ANOVA) tests showed significant difference in protein expression
level of hMSC proteins in different passage number. Image analysis of hMSC proteins shows
SSP 4302, SSP 1406, SSP 1408, SSP 1201, SSP 1407, SSP 1503, SSP 0508, SSP 1306, SSP
1401, SSP 2104, SSP 5607, SSP 0605, and SSP 6302 protein spots were differentially expressed
with significant differences among the passages with confidence interval of p<0.05 (figure 11
and Appendix 1). From figure 11, it was observed that the protein expression of vimentin (SSP
1503) was up regulated from passage 3 to passage 5 and it was down regulated from passage 5 to
passage 9. Similarly, the expression of calreticulin (SSP 0605) was up regulated gradually from
passage 3 to passage 9 as shown in figure 11. It was observed that the protein expression of
meosin C terminal (SSP 6302) was slightly up regulated from passage 3 to passage 4 and it was
gradually down regulated from passage 4 to passage 9 (figure 11). There was a 2 fold decrease in
protein expression between passage 5 and passage 8 in SSP 6302. The change in the protein
expressions can be also visually confirmed by analyzing the 2D gels the intensity of the protein
expression in each passage.
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Figure (11): Proteome analysis of differentially expressed hMSCs proteins using pH 4 to 7 IEF
strips.
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Figure (12): Proteome analysis of differentially expressed hMSCs proteins using pH 6 to 11 IEF
strips.
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Similarly, proteome analysis of hMSCs proteins shows SSP 4304, SSP 3201, SSP 4003, SSP
7302, SSP 7101, SSP 3401, SSP 7004, SSP 3002, and SSP 2403 protein spots differentially
expressed with significant differences among the passages with confidence interval of p<0.05
(figure 12 and Appendix 2). The results show that expression of glyceraldehyde-3-phosphate
dehydrogenase (SSP 3201) were significantly up regulated as hMSCs were cultured and
expanded in 2D environment in vitro for long term. However, the protein expression of
transgelin (SSP 7004) was gradually down regulated from passage 3 to passage 6 and it was up
regulated from passage 6 to passage 9 as shown in figure 12. Poly(rc)-binding protein (SSP
2403) shows significant down regulation as hMSCs were serially sub cultured from passage 3 to
passage 9 in 2D environment.

3. Mass Spectroscopy and Protein Identification
The proteins were successfully identified from mass spectroscopy using Matrix-assisted laser
desorption/ionization – time of flight (MALDI-TOF) technique as summarized in table 2.
Protein Spot

IEF Strips

Protein Identified from Mass Spectroscopy

SSP 4302

pH 4 to 7

Beta actin

SSP 1406

pH 4 to 7

Vimentin

SSP 1408

pH 4 to 7

Vimentin

SSP 1201

pH 4 to 7

Alpha-tropomyosin

SSP 1407

pH 4 to 7

Vimentin

SSP 1503

pH 4 to 7

Vimentin

SSP 1306

pH 4 to 7

Nucleophosmin

SSP 1401

pH 4 to 7

Vimentin
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SSP 2104

pH 4 to 7

Heat shock 70kDa protein (N-terminal frag)

SSP 5607

pH 4 to 7

Prolyl 4-hydroxylase subunit alpha-2

SSP 0605

pH 4 to 7

Calreticulin

SSP 6302

pH 4 to 7

Moesin (C-terminal frag)

SSP 4304

pH 6 to 11

Annexin A2

SSP 3201

pH 6 to 11

Glyceraldehyde-3-phosphate dehydrogenase

SSP 4003

pH 6 to 11

Phosphatidylethanolamine-binding protein 1

SSP 7302

pH 6 to 11

Fructose-bisphosphate aldolase

SSP 7101

pH 6 to 11

Galectin 3

SSP 3401

pH 6 to 11

Alpha-enolase

SSP 7004

pH 6 to 11

Transgelin

SSP 3002

pH 6 to 11

Alpha-crystallin B chain

SSP 2403

pH 6 to 11

Poly(rc)-binding protein

Table (2): Protein identification of differentially expressed hMSCs proteins serially sub-cultured
from passage 3 to passage 9 on 2D culture conditions. These proteins were identified using
MALDI-TOF technique followed by database mining.
Figure 13 shows the mass spectroscopy result to indentify SSP 6302. MALDI-TOF was used
to ionize the sample and measure the mass-to-charge ratio of resulting ions. SSP 6302 was
successfully identified as Meosin (C-terminal fragment) by searching peptide masses into
ExPASy Proteomics server to find the NCBI and GenPept databases for a protein match (table 2,
3 and figure 13). The remaining results for the mass spectroscopy and data base searching for
other protein spots are not shown.
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Figure (13): Mass spectroscopy MALDI-TOF result for protein spot SSP 6302. The peptide
masses were matched using ExPASy proteomics server and the protein was successfully
identified as Meosin (C-terminal fragment).
Table 3 shows the peptide masses and the corresponding peptide sequences obtained from
ExPASy Proteomics server to identify SSP 6302 as Meosin (C-terminal fragment).
Peptide Masses for SSP 6302 obtained Peptide

Sequence

for

Meosin

(C-terminal

from Mass Spectroscopy (m/z)

fragment) from ExPASy database

3314.3884

TAMSTPHVAEPAENEQDEQDENGAEASADLR

1833.1096

KTQEQLALEMAELTAR

1704.9355

TQEQLALEMAELTAR

1531.7444

KTANDMIHAENMR

1473.7303

RKPDTIEVQQMK

1424.6426

HLKALTSELANAR
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1403.5703

TANDMIHAENMR

1360.4662

KAQQELEEQTR

1234.3075

ESEAVEWQQK

1155.2673

QRIDEFESM

1144.2725

RALELEQER

1137.3667

ESPLLFKFR

1080.2226

EDAVLEYLK

1064.1983

EKEELMER

1046.1680

ALTSELANAR

1004.1278

QIEEQTKK

988.0850

ALELEQER

948.1248

ISQLEMAR

920.9110

DRSEEER

Table (3): Protein identification for SSP 6302 by matching peptide masses with their
corresponding sequences using ExPASy database search.
Each m/z obtained from mass spectroscopy corresponds to particular sequence as shown in table
3. Each alphabet in table 3 is the one letter abbreviation for one of the standard amino acid
(Appendix 9).
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IV. Summary, Discussion, and Future Approach
In this study, the protein expression profile of hMSCs was investigated by performing a
proteomic analysis of the serially sub-cultured hMSCs from passage 3 to passage 9. Proteomic
data for differentially expressed proteins during extensive serial subculture of hMSCs for up to
passage 9 were presented.

1. Human MSCs Morphology during Serial 2D Culture
Phase contrast images confirmed the morphological change in hMSCs during serial
subculture in 2D for long term. It was observed that the spindle-shaped hMSCs increases the
sizes, more flattened, and increased number and content of granules in the late passages (figure
3M) compared to the early passages (figure 3A). It was also confirmed by visual assessment that
the proliferation rate decreases in the late passages compared to early passages. The cells were
about 90% – 100 % confluent on early passage in a 7 day culture but their confluency decreases
to 80% – 90% in the late passages. The results were confirmed with Bruder et al. and Wagner et
al. as they also documented the increase in cell size in hMSCs that are serially sub-cultured in
vitro for long term. However, the images did not provide any information on quantitative
structural analysis or molecular changes acquired on hMSCs. Thus, it can be concluded that
phase contrast microscopy is a good technique to confirm surface morphology of hMSCs but it
may not be instrument for analyzing quantitative structural differences among the cells.
Quantitative image analysis tool like Image J is suggested to be used in future to determine
the significant difference in cell size between early passage and late passage hMSCs. This is
because tools like image J analysis software can calculate distance, angles, area, and pixels of
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cells statistics of user-defined selections. This analysis method may reveal important information
regarding the morphological changes acquired during cellular aging of hMSCs.

2. 2D Electrophoresis, Image Analysis, and Mass Spectroscopy
The classical proteomic analysis to profile the global protein expression changes in hMSCs
during serial subculture was used in order to investigate the differentially expressed proteins that
may be responsible for cellular aging of hMSCs. Human MSC Protein profiling was performed
from passage 3 to passage 9 (28 years old donor). Out of more than 100 normalized differentially
expressed protein spots, 21 protein spots were selected for MALDI-TOF analysis.
It was observed that hMSC proteins were expressed in higher quantity on a gel in early
passages compared to late passages. There was more number of protein dots detected on (acidic
proteins) pH 4 to 7 gels compared to (basic proteins) pH 6 to 11 gels (figures 4A and 4B). The
automatic spot detection from PDQuest image analysis tool was manually matched and it was
observed that the expression of protein spots on pH 4 to 7 gels were decreased from passage 3 to
passage 6 and it started to increase from passage 6 to passage 9. Overall, the amount of protein
expression was less in passage 9 compared to passage 3 (figure 5). The amount of protein
expression on pH 6 to 11 gels increased from passage 3 to passage 7 and the number was less in
passage 8 and passage 9 (figure 5). There were 330 proteins spots being matched on pH 4 to 7
gel in three biological triplicates of passage 3 and 180 proteins spots matched on pH 6 to 11 gel
in three biological triplicates of passage 3. While the number of protein spots that were matched
decreases to 176 on pH 4 to 7 gels and 205 on pH 6 to 11 gels in three biological triplicates of
passage 6 (table 1). However, the number of proteins matching slightly increases to 277 on pH 4
to 7 gels and decreases to 164 on pH 6 to 11 gels on passage 9 (table 1). These results suggest
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that there are differences in protein expression profiling of hMSCs during their in vitro culture
and expansion from passage 3 to passage 9. In addition, there were “unique” proteins that were
expressed on passage 3 or passage 9 that were not found in other passages of hMSCs. Those
protein spots will be sent out for mass-spec analysis in the near future. The appearance and
disappearance of hMSC protein spots can reveal differential protein expression and intensity of
those spots can provide quantitative information about protein expression level. This result can
provide important information regarding their characterization of biological roles, clarification of
biological mechanisms, and identification of therapeutic targets and biomarkers.
Image pro analysis provides sum of total intensity of the protein dots expressed on each
gel for both pH 4 to 7 and pH 6 to 11 gels. Differentially expressed proteins were normalized and
clustered to reveal proteins that follow similar trends in their expression along with different
passage numbers (figures 7, 8, 9, 10 and Appendix 3, 4). This information also tells us such
proteins that follow similar trend in their expression may fall under same category of proteins
and related directly or indirectly. The graphs also provide information regarding the up
regulation patterns, down regulation patterns, and the expression level of such proteins in
different passages. This was one of the useful methods for further quantification and selection of
protein spots for mass spectroscopy.
Analysis of variance (ANOVA) was performed with a confidence interval of 95% (p<0.05) to
determine the significant differences in the expression level of selected proteins from passage 3
to passage 9. This is because ANOVA is a powerful method to compare the statistical differences
among multiple samples. Histogram analysis shows the up regulation and down regulation in the
expression profile of such proteins in different passage. PDQuest image analysis, protein
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clustering, ANOVA test and histogram analysis show that SSP 4302, SSP 1406, SSP 1408, SSP
1201, SSP 1407, SSP 1503, SSP 0508, SSP 1306, SSP 1401, SSP 2104, SSP 5607, SSP 0605,
and SSP 6302 protein spots were differentially expressed on pH 4 to 7 gel with significant
differences among the passages with confidence interval of p<0.05 (figure 11 and Appendix 1).
Furthermore, SSP 4304, SSP 3201, SSP 4003, SSP 7302, SSP 7101, SSP 3401, SSP 7004, SSP
3002, and SSP 2403 protein spots were differentially expressed on 2D gel electrophoresis
separated using pH 6 to 11 IEF strips with significant differences among the passages and
confidence level of p<0.05 (figure 12 and Appendix 2).
SSP 4302 (Beta Actin)
Mass spectroscopy and database search identifies SSP 4302 as Beta Actin. It was observed
that Beta Actin was up regulated in expression level from passage 3 to passage 5 by 2 fold
increase and it was down regulated from passage 5 to passage 9 (Appendix 1). Beta Actin is
usually used as a loading control in western blot analysis because this cytoskeleton actin is found
to be constitutively expressed during the analysis. Previous studies have shown that alteration of
cytoskeleton actin in hMSCs have affected the expression of osteogenic differentiation markers,
alkaline phosphatase activity, and calcium deposition44. In addition, it was investigated that
disruption of actin cytoskeleton results increase in adipogenisis and decrease in osteogenesis44.
Thus, differential expression of Beta Actin may play vital role during cellular differentiation and
aging process of hMSCs.
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SSP 2104 (Heat Shock protein 70, N-terminal)
The expression of SSP 2104 (heat shock protein 70, N-terminal) was up from passage 3 to
passage 5 and it was down regulated in passages 6 to 9. Studies have shown that Heat Shock
Protein 70 (HSP70) contribute a protective factor by ensuring proper folding and intracellular
localization of newly synthesized polypeptides, preventing protein aggregation, and dissociate
protein aggregates44,
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. Since HSP70 plays important role during protein modifications,

differential expression of such proteins may directly or indirectly affect the cellular
differentiation and aging of hMSCs.
SSP 1406, SSP 1408, SSP 1407, SSP1503, and SSP 1401 (Vimentin)
Vimentin is class III intermediate filament proteins which are highly expressed in the cells of
mesenchymal origin47. Studies have been performed using vimentin as a specific mesenchymal
marker in differential diagnosis of undifferentiated neoplasms. In addition, vimentin is a
predominant mesenchymal marker that is expressed in epithelial-mesenchymal transition (EMT),
a phenomenon in which epithelial cells acquire mesenchymal phenotype47. Thus, it can be
predicted that vimentin might has key roles during cellular aging and differentiation of hMSCs.
Our results show that the protein expression of SSP 1406 was up regulated from passage 3 to
passage 7 and down regulated in passage 8 and 9. Expression of SSP 1408 was up regulated from
passage 3 to passage 5 and it slightly down regulated in passage 6 and passage 7. It was observed
that there was approximately 2 fold down regulation in expression level in passage 8 and passage
9 compared to passage 4. Similarly, SSP 1407 was up regulated from passage 3 to passage 5 and
it was down regulated in its expression level from passage 5 to passage 9. The standard deviation
for passage 7 was found to be slightly high which may be because of experimental error or
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variation in the gel. The protein expression of SSP 1503 was up regulated from passage 3 to
passage 5 and it was down regulated from passage 5 to passage 9 (figure 11). Also, protein spot
SSP 1401 was up regulated from passage 3 to passage 7 with approximately 2 fold change
between passage 3 and passage 7 and it was down regulated in passages 8 and 9.
SSP 1201 (Alpha-Tropomyosin)
In this study, it was observed that the expression of SSP 1201 (Alpha-Tropomyosin) was up
regulated from passage 3 to passage 4 and it started to down regulate gradually from passage 4 to
passage 9. Tropomyosin is a contractile protein of skeletal muscle responsible for the contraction
of muscles in conjunction with troponins in response to changes in the intracellular calcium ion
concentration48. Previous studies show that calcium deposition of hMSCs increases as these cells
undergo Osteoblasts differentiation49. Thus, Tropomyosin may be directly or indirectly involved
in cellular differentiation and aging of hMSCs.
SSP 1306 (Nucleophosmin)
Human nucleophosmin is a phosphoprotein in nucleoli which is involved in numerous cellular
activities such as ribosome biogenesis, cell proliferation, and regulation of tumor suppressors’
p53 and ARF50. Chan et al. demonstrated that Nucleophosmin is 20 times more abundant in
tumor or proliferating cells than in normal resting cells51. Our result show that the expression of
SSP 1306 (Nucleophosmin)

was up regulated gradually from passage 3 to passage 7

(proliferating stage) and it was down regulated in passage 8 and passage 9 once the cells may
undergo senescence.
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SSP 5607 (prolyl 4-hydroxylase subunit alpha-2)
Prolyl 4-hydroxylase subunit alpha-2 catalyzes the post translational formation of 4hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins52. The expression of
SSP 5607 (prolyl 4-hydroxylase subunit alpha-2) was gradually down regulated from passage 3
to passage 6 and it was up regulated from passage 6 to passage 9.
SSP 6302 (Meosin, C-terminal fragment)
Meosin forms the physical links between the plasma membrane and the actin cytoskeleton 53.
As discussed in Beta Actin, the alterations of cytoskeleton actin in hMSCs have affected the
expression of osteogenic differentiation markers, alkaline phosphatase activity, and calcium
deposition44. Disruption of actin cytoskeleton results increase in adipogenisis and decrease in
osteogenesis44. In this study, it was observed that SSP 6302 (Meosin, C-terminal fragment) was
slightly up regulated from passage 3 to passage 4 and it started to down regulate gradually from
passage 4 to passage 9 where there was 2 fold decrease in the expression in passage 8 compared
to passage 5 (figure 11). Thus, Meosin also may have vital role during cellular differentiation
and aging of hMSCs.
SSP 0605 (Calreticulin)
Calreticulin is calcium binding protein that has been suggested to perform functions in
endoplasmic reticulum, cytoplasm, plasma membrane, and nucleus54. Proteome analysis of SSP
0605 (Calreticulin) shows that its expression was gradually up regulated from passage 3 to
passage 9 as shown in figure 11 and Appendix 1.
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SSP 4303 (Annexin A2)
Proteome analysis of SSP 4303 (Annexin A2) shows its up regulation in passage 3 and
passage 5 and it was down regulated in passages 6 to passage 9. Interestingly, there was sudden
decrease in its expression level in passage 4 compare to passage 3 that may be because of large
standard deviation variation in passage 3 triplicates. Annexin A2 belongs to Annexin protein
family that contains four 70 – 80 amino acids repeats with an annexin consensus sequence. It has
been previously reported that Annexin A2 plays significant role during osteoblast and
chondrocyte differentiation. Gilmore WS et al. investigated that the expression of Annexin A2
are influenced when myeloid cell lines undergo differentiation45. Krisch demonstrated that
inhibiting Annexin channel function prevents terminal differentiation and mineralization in
chondrocytes43. Zhaung et al. also investigated differentially expressed Annexin A2 in MSCs
from adolescent idiopathic scoliosis patients44. Thus, Annexin A2 may be potential factor during
cellular differentiation and aging of Human MSCs.
SSP 3201 (Glyceraldehyde-3-phosphate dehydrogenase)
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a tetramer which is composed of
identical subunits of 37000 molecular weights whose play important role during glycolysis in
converting glyceraldehyde-3-phosphate to 1,3 – diphosphoglycerate55. It was observed that this
enzyme activity may be also regulated through association of enzyme with the cell membrane
and GAPDH bound to red cell membrane is enzymatically inactive55. Allen et al. described that
this poly peptide undergoes a lineage-specific alteration in its interaction with the membrane
during erythroid development. GAPDH may undergo molecular changes during cellular
differentiation and aging of hMSCs. Our results show that SSP 3201 (Glyceraldehyde-343

phosphate dehydrogenase) shows significant up regulation in the expression as hMSCs were
cultured and expanded in vitro from passage 3 to passage 9 (figure 12).
SSP 4003 (Phosphatidylethanolamine-binding protein 1)
Phosphatidylethanolamine-binding proteins (PEBPs) belong to evolutionarily conserved
family proteins with significant biological functions such as lipid binding and signal
transduction56. SSP 4003 (Phosphatidylethanolamine-binding protein 1) shows slightly up
regulation from passage 3 to passage 4, gradually down regulated from passage 4 to passage 6,
and the expression was up regulated from passage 6 to passage 9.
SSP 7101 (Galectin 3)
Galectin-3 belongs to galectins protein family which is involved in acute inflammatory
response including neutrophil activation and adhesion, activation of mast cells, immune
regulation, tumor evasion, apoptosis, and differentiation57,
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. The protein expression of SSP

7101 (Galectin 3) shows gradual down regulation from passage 3 to passage 9 by approximately
2 fold decrease.
SSP 3401 (Alpha-enolase)
Alpha-enolase belongs to cytosolic proteins which are made up two identical subunits and
found in various tissues including liver whose primary role is in glycolytic pathways. Previous
studies have demonstrated that the expression of alpha enolase increases in mitocally active cells
and remains undetectable level in quiescent cells59. SSP 3401 (Alpha-enolase) shows that its
expression level was slowly down regulated from passage 3 to passage 6 and it started to up
regulate from passage 6 to passage 9.
44

SSP 7004 (Transgelin)
Transgelin belongs to the calponin family whose primary function includes actin crosslinking/gelling protein and involves in calcium interactions and contractile properties of the cell
that may contribute to replicative senescence61.

Yamamura et al. demonstrated that the

expression of transgelin (SM22α) gene was decreased during undifferentiation and proliferation
of smooth muscle cells and it was expressed in proliferating cells but was down regulated in
quiescent cultures in non-SMC mesenchymal cells60. Other studies show that transgelin were
over expressed in senescent human fibroblast which also consistent to our data61. In this study,
SSP 7004 (Transgelin) shows similar trend in its expression level as Alpha-enolase. The
expression of transgelin was also slowly down regulated from passage 3 to passage 6 and it
started to up regulate from passage 6 to passage 9 (figure 12).
SSP 3002 (Alpha-crystallin B chain)
Alpha-crystallin B chain belongs to the family of heat shock proteins whose primary function
is to act as a chaperone for preventing unfolded proteins from forming aggregates and
denaturation62. In this study, SSP 3002 (Alpha-crystallin B chain) shows similar expression in
passage 3 and passage 4. However, it was down regulated significantly in passage 5 then the
expression level started to up regulate from passage 5 to passage 9 gradually.
SSP 2403 (poly (rc)-binding protein)
Poly (rc)-binding protein plays vital role in mRNA stability and translational regulation63.
Previous studies have shown that the activity of this protein is lowered during phosphorylation
(post translational modification)
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. Our data shows that the protein expression profile of SSP
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2403 (poly(rc)-binding protein) shows significant down regulation as hMSCs were serially sub
cultured from passage 3 to passage 9 in 2D environment (figure 12). It may be due to post
translational modification of this protein as hMSCs are cultured and expanded in vitro for long
term.
In this study, the protein expression profiles of hMSCs during continuous subculture are
shown. Proteomic approach yielded several candidate proteins potentially involved directly or
indirectly during cellular aging of hMSCs during extensive serial subculture. However, the
differentially expressed proteins need to be confirmed by Western blot analysis for their
expression and the change in patterns of selected proteins should be in agreement with two
dimensional results. In addition, the expression of selected genes can be further studied at the
mRNA level with RT-PCR. Thus, the results of western blot and RT-PCR analysis will confirm
the reability of the proteomic analysis. Furthermore, hMSCs can be expanded and cultured more
than passage 9 and proteomic analysis can be performed in order to determine any significant
changes in the protein expression on their late passages compared to early passages. In addition,
Amount of total protein loaded during 2-DE experiments can be manipulated to show the
changes of protein expression at two extreme cases (saturated and very-low expression). The
dimension and the concentration of gels can be manipulated so that maximum amount of proteins
can be detected from the cells followed by protein validation.
It would be interesting to use scaffolds such as self-assembling peptide hydro gels to culture
and expanded hMSCs and perform proteomic analysis to compare with 2D culture data. hMSCs
in vivo have three dimensional environments where cells interact with extracellular matrix
(ECM) and with each other. Hence, recreating 3-D conditions and structures with scaffolds in
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vitro are critical for the proper understanding and implementing different clinical therapies using
hMSCs. Biological scaffold such as PuraMatrix mimics synthetic in vitro and in vivo ECM and
may be used to culture and expand hMSCs as a critical component to successful 3-D cell
proliferation and/or differentiation maintaining their phenotype. Since a 3-D culture method
mimics several aspects of the in vivo environment, it might be used to expand hMSCs for long
term maintaining their stem-stage and maximize their effectiveness in clinical applications.
Furthermore, two dimensional reference maps can be created to facilitate the identification of
quantitative and qualitative changes in protein expression profile in response to serial subculturing of hMSCs. Our study may lead to more focused and in depth research on the effects of
long term culture on cellular aging of hMSCs.
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V. Conclusions
In this study, the protein expression profiles of serially sub-cultured hMSCs on 2D
environment were performed using classical proteomic methods (2D electrophoresis and mass
spectroscopy) in order to investigate the differentially expressed proteins. It was investigated that
Calreticulin, Glyceraldehyde-3-phosphate dehydrogenase, and alpha-crystallin B chain were up
regulated in protein expression while Moesin (C-terminal frag), Poly (rc)-binding protein, Alphatropomyosin, Annexin A2, and Galectin 3 were down regulated. Similarly, it was found that
Vimentin, Beta actin, Nucleophosmin, and Heat shock protein 70 (N-terminal frag) showed up
regulation in initial passages and down regulation in late passages while Transgelin, Prolyl 4hydroxylase

subunit

alpha-2,

Phosphatidylethanolamine-binding

protein

1,

Fructose-

bisphosphate aldolase, and Alpha-enolase showed down regulation in early passages and up
regulation on late passages. The morphology of hMSCs over passage 3 to passage 9 suggests
there may be molecular alterations within the cells. From 2D electrophoresis, it was found that
there are many proteins differentially expressed in different passages of hMSCs, suggesting that
these proteins may be directly or indirectly involved during cellular aging of hMSCs during
extensive serial subculture. The use of self-assembling peptide hydrogel may help to culture and
expand hMSCs for long term in vitro by maintaining their phenotype and function. This data
may be used for characterization of biological roles, clarification of biological mechanisms, and
identification of therapeutic targets and biomarkers. However, validation of differentially
expressed proteins should be performed by western blot and/or RT-PCR in order to confirm the
expression of selected proteins or genes that shows passage dependent regulation.
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VII. Appendix
1. PDQuest Image Analysis for pH 4 to 7 gels

Figure (A): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 4302 was successfully identified as Beta Actin via mass spectroscopy and
database searching. It was observed that this protein is up regulated from passage 3 to passage
5 by 2 fold increase and it starts to down regulate gradually from passage 5 to passage 9.

Figure (B): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 1406 was successfully identified as Vimentin via mass spectroscopy and
database searching. It was observed that this protein is up regulated from passage 3 to passage
5 by 2 fold increase, up regulated from passage 5 to passage 7 by another 2 fold increase and it
down regulated in passage 8 and passage 9.
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Figure (C): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 1408 was successfully identified as Vimentin via mass spectroscopy and
database searching. It was observed that this protein is up regulated from passage 3 to passage
5 and it starts to down regulate in passage 6 to passage 9.

Figure (D): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 1201 was successfully identified as Alpha-Tropomyosin via mass spectroscopy
and database searching. It was observed that this protein was up regulated from passage 3 to
passage 4 and it gradually down regulated from passage 4 to passage 9.
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Figure (E): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 1407 was successfully identified as Vimentin via mass spectroscopy and
database searching. It was observed that this protein was up regulated from passage 3 to
passage 5 and it was down regulated from passage 5 to passage 9.

Figure (F): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 1306 was successfully identified as Nucleophosmin via mass spectroscopy and
database searching. It was observed that this protein was up regulated gradually from passage 3
to passage 7 and it was down regulated in passage 8 and passage 9.

56

Figure (G): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 2104 was successfully identified as Heat shock Protein 70 (N-terminal) via
mass spectroscopy and database searching. It was observed that this protein was up regulated
from passage 3 to passage 5 and it was down regulated in passages 6, 7, 8, and 9.

Figure (H): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 5607 was successfully identified as Prolyl 4-hydroxylase subunit alpha-2 via
mass spectroscopy and database searching. Image analysis shows that this protein was
gradually down regulated from passage 3 to passage 6 and it was up regulated from passage 6
to passage 9.
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Figure (I): Proteome analysis of differentially expressed Human MSCs proteins using pH 4 to 7
IEF strips. SSP 0605 was successfully identified as Calreticulin via mass spectroscopy and
database searching. Image analysis shows that this protein was gradually up regulated from
passage 3 to passage 9.
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2. PDQuest Image Analysis for pH 6 to 11 gels

Figure (J): Proteome analysis of differentially expressed Human MSCs proteins using pH 6 to
11 IEF strips. SSP 4304 was successfully identified as Annexin A2 via mass spectroscopy and
database searching. Image analysis shows that this protein was up regulated in passage 5
compared to passage 3. However, it was down regulated in passage 4. There was significant
down regulation from passage 5 to passage 9.

Figure (K): Proteome analysis of differentially expressed Human MSCs proteins using pH 6 to
11 IEF strips. SSP 4003 was successfully identified as Phosphatidylethanolamine-binding
protein 1 via mass spectroscopy and database searching. There was gradual down regulation in
protein expression from passage 3 to passage 6 and the expression was up regulated from
passage 6 to passage 9.
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Figure (L): Proteome analysis of differentially expressed Human MSCs proteins using pH 6 to
11 IEF strips. SSP 7302 was successfully identified as Fructose-bisphosphate aldolase via mass
spectroscopy and database searching. There was gradual down regulation in protein expression
from passage 3 to passage 6 and the expression was up regulated from passage 6 to passage 9.

Figure (M): Proteome analysis of
differentially expressed Human MSCs proteins using pH 6 to 11 IEF strips. SSP 7101 was
successfully identified as Galectin 3 via mass spectroscopy and database searching. PDQuest
image analysis shows that the protein was gradually down regulated from passage 3 to passage
9 by 2 fold.
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Figure (N): Proteome analysis of differentially expressed Human MSCs proteins using pH 6 to
11 IEF strips. SSP 3401 was successfully identified as Alpha-enolase via mass spectroscopy and
database searching. PDQuest image analysis shows that the protein was slowly down regulated
from passage 3 to passage 6 and it starts to up regulate from passage 6 to passage 9.

Figure (O): Proteome analysis of differentially expressed Human MSCs proteins using pH 6 to
11 IEF strips. SSP 3002 was successfully identified as Alpha-crystallin B chain via mass
spectroscopy and database searching. The protein expression was similar for passage 3 and
passage 4 and it was down regulated significantly in passage 5. The protein expression was then
up regulated gradually from passage 5 to passage 9.
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3. Clustering of hMSC proteins from pH 4 to 7 gels
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Figure (A): Human MSCs protein expression profiling along with different passage numbers.
Proteins were separated using 2D electrophoresis with pH 4 to 7 for first dimension and 12.5%
Tris HCl gel for second dimension. Each SSP number corresponds to single protein. It was
observed that there are proteins that follow similar trend in their expression as Human MSCs
are cultured and expanded in vitro on 2D culture condition.
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4. Clustering of hMSC proteins from pH 6 to 11 gels

Figure (B): Human MSCs protein expression profiling along with different passage numbers.
Proteins were separated using 2D electrophoresis with pH 6 to 11 for first dimension and 12.5%
Tris HCl gel for second dimension. Each SSP number corresponds to single protein. It was
observed that there are proteins that follow similar trend in their expression as Human MSCs
are cultured and expanded in vitro on 2D culture condition.
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5. Protocol for 2DE Sample Preparation
1. Lysis buffer preparation: Lysis buffer contains 9.5 M Urea (Sigma Aldrich), 2% CHAPS
(GE Healthcare), 1% w/v Dithiothreitol (GE Healthcare), 0.8% w/v Pharmalyte pH 3.0 –
10.0 (GE Healthcare), and Complete mini protease inhibitors cocktail tablets (Roche
Diagnostics Ltd, Lewes, UK). Dissolve x gms of Urea in 25 ml of water by maintaining
95oC. Once the Urea is fully dissolved, let the solution cool down at room temperature
for 15 minutes. Dissolve x g CHAPS, x g DTT, x µl Pharmaltye, and 5 tablets of protease
inhibitor in the Urea solution and make up to 50 ml with water.
2. Cell Lysis: Trypsinize the cell and wash the cell pellet once with cold PBS. Add 500 µl
of lysis buffer and incubate on ice bath for 30 minutes, vortexing every 10 minutes.
Centrifuge the sample at maximum speed for 12 minutes. Collect the supernatant and
discard the cell pellet. Store the sample at – 80oC until use.
3. 2D Clean up kit: transfer 1 – 500 µg of protein in a fianl volume of 100 µl into a 1.5 ml
microcentrifuge tube. Add 300 µl precipitating agent 1 to the protein sample and mix
well by vortexing. Incubate on ice for 15 minutes. Add 300 µl precipitating agent 2 to the
mixture of protein and precipatating agent 1 and mix well. Centrifuge the tube at
maximum speed for 20 mintues and remove and sicard the supernatant using a pipet
without disturbing the pellet. Add 40 µl of wash reagent 1 on the top of pellet and
centrifuge at maximum speed for 5 minutes. Remove and discard the suparnatant and add
25 µl of distilled deionized water and vortex for 10 – 20 seconds. Add 1 ml of wash
reagent 2 (prechilled at – 20oC for at least 1 hour) and 5 µl of wash 2 additive. Vortex the
tube for 1 minute. Incubate the tube at – 20oC for 30 minutes by vortexing the tube for 30
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seconds every 10 minutes. Next, centrifuge the tube at maximum speed for 20 minutes
and remove and discard the supernatant. Resuspend each pellet by adding 200 µl of
reswelling solution. Measure the protein concentration of the sample using Bradford
method. Use 200 µg of protein in 200 µl total volume of reswelling solution for overnight
rehydration prior to the first dimension.

6. Protocol for Two-Dimensional Electrophoresis
1. The protein samples after Ready Prep 2D clean up kit and Bradford assay should be used
immediately or if stored frozen at – 80oC should be thawed on ice bath.
2. Passive rehydration of Immobiline Dry gel (IPG) strips: Dilute an aliquot of each sample
containing 200 µg of Human MSCs proteins with rehydration buffer to a volume of 200
µl. Pipet each sample into one groove of the reswelling tray (GE Healthcare). Peel off the
protective cover sheets from the IPG strips and place the strips into the grooves carefully
(gel upside down) with clean forceps ensuring no formation of bubbles. Incubate the tray
at room temperature for 1 hour until most of the samples have been absorbed by IPG
strips. Cover the strips with 3 ml of DryStrip cover fluid (GE Healthcare) to prevent
evaporation during rehydration process. Close the lid and allow the strips to rehydrate at
room temperature for 14 hours.
3. Rinsing IPG strips: Remove the IPG strips from the reswelling tray using clean forceps
after rehydration is complete. Rinse them with deionized water and place them on
saturated filter paper with gel side up. Blot them gently with another filter paper soaked
on deionized water, to remove excess water and rehydration buffer in order to prevent
urea crystallization on the surface of the gel during IEF.
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4. Preparation for first dimension (Isoelectric Focusing): Clean and dry the isoelectric
focusing tray, template for strip alignment, and electrodes. Set the thermostatic circulator
at 20oC and turn on the instrument at least 20 minutes prior to IEF separation. Pipet a few
drops of DryStrip cover fluid onto the cooling plate for good contact between strip tray
and cooling plate and place the focusing tray into the Protean IEF Cell. Using forceps,
place a paper wick soaked on 10 µl of deionized water at each end to cover wire
electrodes. Transfer the IPG strips in the grooves of the focusing tray with gel side down
maintaining the polarity. The basic ends of the IPG strips must be at the cathodic side of
the apparatus. Cover each IPG strips with 3 ml of DryStrip fluid and close the lid of
focusing tray.
5. Programming Protean IEF Cell for first dimension (Isoelectric Focusing): Maintain the
cell temperature 20oC with maximum current of 50 µA per IPG strip. Set the following
parameters in Protean IEF Cell to run IPG strips pH 4 – 7 and pH 6 – 11 and press start to
initiate the electrophoresis run.
Steps

Start Voltage

End Voltage

Set Time

Ramp

Temperature

Step 1

0V

250 V

15 minutes

Rapid

20oC

Step 2

250 V

8000 V

1 hour

Rapid

20oC

Step 3

8000 V

8000 V

30000 V-Hr

Rapid

20oC

6. IPG strips storage: When the IEF run has been completed, remove the gel from the
apparatus and transfer them gel side up into a new disposable rehydration tray. Hold the
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IPG strips vertically with forceps to drain out the excess cover fluid from the strip. Store
the IEF strips at – 80oC if they are not immediately used for second dimension separation.
7. Equilibration of IPG gel strips: If the IPG strips were stored at – 80oC then thaw them
onto the lab bench for 10 – 15 minutes. Equilibrate IPG gel strips with 4 ml of
equilibrium buffer I. Next, place the tray on an orbital shaker and gently shake for 10
minutes. Discard the equilibrium buffer I and equilibrate IPG gels with 4 ml of
equilibrium buffer II for 10 minutes. Rinse the IPG strips with 1X Tris-Glycine-SDS
running buffer and blot them on filter paper to remove excess liquid.
8. Preparation for second dimension (SDS-PAGE): Clean the Protean Dodeca Cell system
with deionized water and place the system on a stir plate. Remove the 12.5 %
polyacrylamide Tris-HCl gel cassette from the storage container, gently remove the
comb, and rinse the wells thoroughly with deionized water. Remove the tape from the
bottom of the cassette and insert the criterion gel into one of the slots in the Dodeca Cell
system by ensuring the upper buffer chamber of the gel is facing towards the center of the
cell. Fill the upper buffer chamber in each criterion gel with 60 ml of running buffer.
Insert the IPG strips on the SDS-PAGE gels and gently slide the strips into place
avoiding any air bubbles. Load 15 µl of protein standard on the well and fill the tank to
the fill level line indicated on the tank. Next, place the lid on the tank aligning the color
coded banana plugs and jacks and then slide the lid down in the place.
9. Programming Protean Dodeca Cell for second dimension (SDS-PAGE): Connect the
banana plugs to the PowerPac 200 power supply and set voltage to 200 V. Adjust the
running time for 1 hour and press start. The gels can be subjected to any suitable running
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time until the bromophenol blue tracking dye and protein standard reaches the bottom of
the gels.
10. Gel removal: After the electrophoresis is complete, turn off the power supply and
disconnect the electrical leads. Remove the lid and carefully lift out the criterion gel
cassette and discard the running buffer. Rinse the dodeca tank and lid with deionized
water after use. Use the cassette opening tool built into the lid to break the weld joint on
the criterion gel cassette.
11. Gel Staining: Rinse the gel three consecutive times with 30 ml of deionized water for 10
minutes each. Stain the gels from pH 4 – 7 and pH 6 – 11 with Coomassie blue from BioRad and Invitrogen respectively for 1 hour. For the gels stained with Coomassie blue
from Bio-Rad, destain them with 40% methanol and 10% acetic acid for 2 hours and
destain Invitrogen Coomassie blue stained gels with deionized water for 2 hours. Store
the gels at 4oC to 8oC until the images were taken.
12. Image Capture: Images were obtained with ChemiDocTM XRS Molecular Imager
following the protocol from Bio-Rad. The gels stored back to 4oC - 8oC until protein
spots excision.

7. Protocol for PDQuest Image Analysis
1. Open the PDQuest software 8.0 and crop the images obtained from ChemiDocTM XRS
Molecular Imager using advanced crop tool, ensuring the proper alignment of the gels.
2. Open an experiment wizard and start a new experiment. Name the experiment and select
the location to save the experiment.
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3. Locate images to add to the experiment and group the gel images that are from the same
passages. For example, select three gels from passage 3 and group them as “P3”.
4. Process the images in the experiment by choosing spot detection and matching
parameters. For spot detection parameter, choose spot detection wizard.
5. Choose a master gel from one of the gel image from passage 3 (control). Select add spots
from replicate groups to the master gel image based on consensus within the group. Add
spots present in all but “1” of the group members.
6. Choose normalization parameters to “total quantity in valid spots”.
7. Create analysis sets using following parameters: Specify “passage 3” as the control group
in the experiment. For quantitative analysis, assign 2 fold changes that are statistically
significant to a level of 95% per group in the analysis set. Check the boxes for “create
union and intersection of all of the above analysis sets, and launch spot review tool when
the experiment is finished”.
8. Choose a passage 3 gel that was previously assigned as master gel. Select the faint spot,
small spot and large spot by visual inspection. Check the box for Gaussian distribution
and click proceed. Adjust the sensitivity to detect the spots on the gels automatically and
click ok.
9. Once the experiment is done, run the matching tool. Match the spots manually, by visual
inspections, which are not properly matched from automatic spot detection.
10. Open the spot review tool for further analysis of individual spots and export the excel file
for the quantitative analysis.
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8. Protocol for Mass Spectroscopy
1. Transfer protein spots to a clean tube containing 100 µl of 0.01M DTT and 0.1M Tris, pH
8.5.
2. Incubate them in a heating block at 55oC for 1 to 2 hours.
3. Discard the solution after cooling down at room temperature and add 100 µl of 0.03M
iodoacetamide and 0.1M Tris, pH 8.5. Incubate the tube in dark for 30 minutes and
discard the liquid.
4. Wash the gels twice with 100 µl of 0.05M Tris, pH 8.5 and 30% acetonitrile for 20
minutes in a orbital shaker followed by 100% acetonitrile for 1 – 2 minutes.
5. Discard the solution and dry the spots with Speed-Vac concentrator for 30 minutes.
6. Digest the gels by adding 0.08 µg of modified trpsin (Sequencing grade, Roche
Molecular Biochemicals) and 13 – 15 µl of 0.025M Tris, pH 8.5.
7. Incubate the tube overnight in a heating block at 32oC and extract peptides with 2X 50 µl
50% acetonitrile and 2% Trifluoroacetic acid (TFA). Dry the extract and re-suspend in a
matrix solution.
8. Prepare matrix solution by adding 10 mg/ml of 4-hydroxy-α-cyanocinnamic acid in 50%
acetonitrile and 0.1% TFA.
9. Add two internal standards, angiotensin and ACTH 7-38 peptide, were added to the
matrix solution.
10. Dissolve the digest in 3 µl matrix/standard solution and spot 0.5 µl of the sample onto the
sample plate.
11. Dry the spots and wash twice with water.
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12. Perform MALDI mass spectrometric analysis in the linear mode using Applied
Biosystems Voyager DE Pro mass spectrometer.
13. Enter peptide masses into search programs to search NCBI and GenPept databases for a
protein match.
14. Modify Cysteine residues by carboxyamidomethyl and set error tolerance at 0.5 Da for
average masses.

9. Names and abbreviation of standard amino acids
Amino Acids

Three-Letter Abbreviation

One-Letter Abbreviation

Alanine

Ala

A

Arginine

Arg

R

Asparagine

Asn

N

Aspartic Acid

Asp

D

Cysteine

Cys

C

Glutamic Acid

Glu

E

Glutamine

Gln

Q

Glycine

Gly

G

Histidine

His

H

Isoleucine

Ile

I

Leucine

Leu

L

Lysine

Lys

K

Methionine

Met

M

Phenylalanine

Phe

F

Proline

Pro

P
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Serine

Ser

S

Threonine

Thr

T

Tryptophan

Trp

W

Tyrosine

Tyr

Y

Valine

Val

V
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